Stock PHRMASI6 PHAARMASIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Phaarmasia Limited

Equities

PHRMASI6

INE486I01016

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:56 2024-07-03 EDT 		5-day change 1st Jan Change
53.69 INR +1.13% Intraday chart for Phaarmasia Limited -3.88% +36.37%
05-25 Phaarmasia Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
05-25 Phaarmasia Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Capitalization 1 250.9 115 94.89 169.6 211.3 159.8
Enterprise Value (EV) 1 251.2 115 95.38 167.6 210.7 156.9
P/E ratio 43.8 x 14.8 x 17.6 x 54.4 x -13.6 x -12.7 x
Yield - - - - - -
Capitalization / Revenue 1.24 x 0.45 x 0.39 x 0.83 x 1.23 x 0.58 x
EV / Revenue 1.24 x 0.45 x 0.39 x 0.82 x 1.22 x 0.57 x
EV / EBITDA 21.3 x 8.97 x 6.91 x 20.5 x -16.6 x -13.6 x
EV / FCF -787 x -68.6 x -149 x 25.3 x 48.1 x 10.7 x
FCF Yield -0.13% -1.46% -0.67% 3.95% 2.08% 9.36%
Price to Book 2.09 x 0.9 x 0.71 x 1.24 x 1.75 x 1.48 x
Nbr of stocks (in thousands) 6,827 6,827 6,827 6,827 6,827 6,827
Reference price 2 36.75 16.85 13.90 24.85 30.95 23.40
Announcement Date 18-09-22 19-09-06 20-09-07 21-09-01 22-09-05 23-07-06
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net sales 1 201.8 257 244.5 204.1 172.2 274.9
EBITDA 1 11.82 12.82 13.8 8.165 -12.73 -11.51
EBIT 1 7.159 8.207 9.813 4.753 -15.66 -14.05
Operating Margin 3.55% 3.19% 4.01% 2.33% -9.09% -5.11%
Earnings before Tax (EBT) 1 6.794 8.311 9.607 4.787 -15.62 -14.32
Net income 1 5.728 7.775 5.398 3.12 -15.47 -12.59
Net margin 2.84% 3.03% 2.21% 1.53% -8.99% -4.58%
EPS 2 0.8400 1.140 0.7900 0.4570 -2.270 -1.844
Free Cash Flow 1 -0.3193 -1.676 -0.6414 6.623 4.384 14.68
FCF margin -0.16% -0.65% -0.26% 3.24% 2.55% 5.34%
FCF Conversion (EBITDA) - - - 81.12% - -
FCF Conversion (Net income) - - - 212.29% - -
Dividend per Share - - - - - -
Announcement Date 18-09-22 19-09-06 20-09-07 21-09-01 22-09-05 23-07-06
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net Debt 1 0.28 - 0.48 - - -
Net Cash position 1 - 0 - 2.07 0.55 2.84
Leverage (Debt/EBITDA) 0.024 x - 0.0349 x - - -
Free Cash Flow 1 -0.32 -1.68 -0.64 6.62 4.38 14.7
ROE (net income / shareholders' equity) 4.84% 6.26% 4.12% 2.31% -12% -11%
ROA (Net income/ Total Assets) 2.16% 1.86% 1.83% 1.07% -4.54% -3.54%
Assets 1 265.4 418.2 294.2 291.5 340.9 355.8
Book Value Per Share 2 17.60 18.80 19.60 20.00 17.70 15.80
Cash Flow per Share 2 0.2800 0.2800 0.0500 0.3800 0.1200 0.8100
Capex 1 9 1.17 - - - 0.26
Capex / Sales 4.46% 0.46% - - - 0.09%
Announcement Date 18-09-22 19-09-06 20-09-07 21-09-01 22-09-05 23-07-06
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PHAARMASIA LIMITED Stock Phaarmasia Limited
+36.37% 4.34M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.55% 816B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+39.31% 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.83% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.15% 323B
ABBVIE INC. Stock AbbVie Inc.
+7.09% 293B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.28% 238B
ROCHE HOLDING AG Stock Roche Holding AG
+0.90% 222B
NOVARTIS AG Stock Novartis AG
+13.40% 218B
AMGEN INC. Stock Amgen Inc.
+7.87% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PHRMASI6 Stock
  4. Financials Phaarmasia Limited